ENTOD Pharmaceuticals launched India’s first Vitamin D3 enriched lubricating eye drops, a first in India

New Delhi, 31st May 2024: ENTOD Pharmaceuticals, a leader in the Indian pharmaceutical industry, has launched their latest innovation, Vitamin D3 enriched lubricating eye drops. These novel formulations represent a significant advancement in ocular health, providing targeted relief for individuals suffering from dry eyes, a first-of-its-kind offering in India. Vitamin D3 has now been incorporated into some of ENTOD Pharmaceutical’s selected lubricant eye drop brands that are currently prescribed by eye doctors for dry eyes.

Dry eye syndrome is a prevalent condition characterised by discomfort, irritation, and even vision impairment. The main causes of dry eyes are environmental factors, Vitamin deficiencies, Poor blinking habits, Contact lenses, Digital devices, Smoking, Refractive surgeries and more.

Commenting on the launch, Mr. Nikkhil K Masurkar, CEO of ENTOD Pharmaceuticals said, “As a pharmaceutical company committed to improving healthcare outcomes, we realised the urgent need for effective solutions to address dry eye syndrome. By utilising the power of Vitamin D3 and other key ingredients, we aim to provide effective relief for individuals suffering from dry eyes, ultimately improving their quality of life. Adding Vitamin D3 to routine dry eye treatment improves ocular surface hemostasis parameters, results in better tear stability and improved tear osmolarity, and helps modulate corneal wound healing. Vitamin D3 enriched lubricating eye drops would only be available through health care professional prescriptions. Our passion for innovation and excellence drives us to offer impactful interventions that empower individuals to safeguard their vision.”

Emphasising the significant impact of Vitamin D on eye health, Dr Ganesh kalyanshetty, Cataract & cornea Surgeon , MBBS, MS Ophthalmology KMC EYE & SKIN HOSPITAL ULWE NAVI MUMBAI., “Vitamin D deficiency is increasingly recognised as a significant contributor to various eye conditions, including dry eye syndrome. Inadequate levels of Vitamin D not only compromise tear production but also impair the health of the ocular surface, predisposing individuals to discomfort and vision disturbances. The launch of Vitamin D3 enriched lubricating eye drops by ENTOD Pharmaceuticals marks a crucial moment in its approach to combating these issues. This advancement holds promise in enhancing the ocular health and overall well-being of countless individuals across the nation.”

Vitamin D3 deficiency is a widespread issue, particularly in regions with limited sunlight exposure like India. Studies have shown that inadequate levels of Vitamin D3 can adversely affect eye health, leading to conditions such as age-related macular degeneration, diabetic retinopathy, and dry eye syndrome. According to a report published in May 2020, nearly 76% of Indians suffer from Vitamin D deficiency and insufficiency, with the prevalence highest among young adults. Recognising the critical role of Vitamin D in maintaining overall health, ENTOD aspires to address this pressing issue through their innovative eye care solution.